Skip Navigation


Annals of Oncology Advance Access originally published online on July 8, 2005
Annals of Oncology 2005 16(10):1567-1568; doi:10.1093/annonc/mdi315
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/10/1567    most recent
mdi315v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Raina, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raina, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Editorial

Doing cancer trials in India: opportunities and pitfalls

V. Raina, Professor*

Dept. of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Medical Oncology, New Delhi, India

* E-mail: vinodraina@hotmail.com

The first 10% of the full text of this article appears below.

India's population currently is 1.03 billion and is growing at 1.7% per year, which means that the country is adding 18 million people every year. In spite of the huge growth in population, India has made tremendous progress from being a net food importer in the 1970s to a net food and technology exporter and a large manufacturing hub. Per capita income has doubled since 1992 and there is an unprecedented economic boom in certain parts of the country fuelled by economic reforms and liberalization. Life expectancy was 35 years at independence in 1947; today it is ~65 years.

Cancer incidence is generally much lower here than in the developed world, the average national age adjusted rate being ~120 compared with >300 per 100 000 per year in developed countries [1Go]. The causes of low cancer rates have been variously attributed to under-reporting, ethnic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
R. Ali and V. Raina
Developing innovative models for North-South cooperation in clinical research--experience from the INDOX Cancer Research Network
Ann. Onc., May 1, 2008; 19(5): 831 - 833.
[Full Text] [PDF]

Home page
 Ann OncolHome page
D. J. Kerr
Concordia res parvae crescent
Ann. Onc., January 1, 2006; 17(1): 3 - 4.
[Full Text] [PDF]